TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin July 23, 2010
TCL Archive NCI grants funding: Institute Contemplates Increase In RFA Support Due to Large Number Of Grant Applications July 9, 1999
